touchPODCAST

Listen to key experts from a multidisciplinary team review and discuss why and how to implement continuous glucose monitoring in T2D.

The multidisciplinary team

• Endocrinologist: Prof Tina Vilsbøll
• Primary Care Physician: Dr Gihane Zarifa
• Nurse specialist: Ms. Lori Berard
• Patient advocate: Mr. Ostap Soroka

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

 

For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/

 

 

Listen to key experts from a multidisciplinary team review and discuss evolving options for insulin therapy. 

The multidisciplinary team

• Endocrinologist: Prof Tina Vilsbøll
• Primary Care Physician: Dr Gihane Zarifa

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/

 

 

Listen to key experts from a multidisciplinary team review and discuss clinical inertia in T2D.

The multidisciplinary team

• Endocrinologist: Prof Tina Vilsbøll
• Primary Care Physician: Dr Gihane Zarifa
• Patient advocate: Mr. Ostap Soroka

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/

 

touchSYMPOSIUM for touchRESPIRATORY

Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France.

Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC. 

Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation

Session 2: Prof.  Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC

Session 3: Prof. David Planchard discusses the complexities of using TROP2 as a biomarker for patient selection

Session 4: A panel discussion offering practical approaches for managing adverse effects associated with TROP2-targeted ADCs in clinical practice, with Q&A.

This touchPODCAST is for HCPs outside of the UK.

This activity is funded by an independent medical education grant from Daiichi Sankyo and AstraZeneca and is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchoncologyime.org/

touchSYMPOSIUM for touchONCOLOGY

Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France.

Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC. 

Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation

Session 2: Prof.  Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC

Session 3: Prof. David Planchard discusses the complexities of using TROP2 as a biomarker for patient selection

Session 4: A panel discussion offering practical approaches for managing adverse effects associated with TROP2-targeted ADCs in clinical practice, with Q&A.

This touchPODCAST is for HCPs outside of the UK.

This activity is funded by an independent medical education grant from Daiichi Sankyo and AstraZeneca and is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchoncologyime.org/

touchPANEL DISCUSSION for touchNEUROLOGY

Listen to a panel of world-leading experts in lysosomal storage disorders  explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of alpha-mannosidosis, with the aim of optimizing patient outcomes.

The experts

• Dr Barbara K. Burton, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
• Dr Can Ficicioglu, Children's Hospital of Philadelphia, PA, USA
• Dr Christina Lampe, University of Giessen, Giessen, Germany

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Chiesi USA, Inc. 

The activity is jointly provided by USF Health and touchIME. 

For further information visit: touchneurologyime.org/

touchPANEL DISCUSSION for touchENDOCRINOLOGY

Listen to a panel of world-leading experts in lysosomal storage disorders  explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of alpha-mannosidosis, with the aim of optimizing patient outcomes.

The experts

• Dr Barbara K. Burton, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
• Dr Can Ficicioglu, Children's Hospital of Philadelphia, PA, USA
• Dr Christina Lampe, University of Giessen, Giessen, Germany

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Chiesi USA, Inc. 

The activity is jointly provided by USF Health and touchIME. 

For further information visit: touchendocrinologyime.org/

touchIN CONVERSATION for touchONCOLOGY

Listen to two expert gynaecologic oncology specialists discuss the evolving role of immunotherapy in the treatment of advanced/recurrent endometrial cancer. They explore how immune checkpoint inhibitors are reshaping standards of care across lines of therapy, highlight key practical considerations for optimizing patient selection and management, and examine emerging data that may influence future treatment paradigms.

The experts

• Dr Alexandra Leary, Gustave Roussy Cancer Center, Villejuif, France
• Dr Juan Francisco Grau, Gustave Roussy Cancer Center, Villejuif, France

This touchPODCAST is for HCPs outside of the USA and UK only. 

This activity is funded by an independent medical education grant from GSK.

This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchoncologyime.org/ 

touchPANEL DISCUSSION for touchHAEMATOLOGY

Listen to three experts as they explore the burden of myelofibrosis and anaemia and/or thrombocytopenia, discuss targeted treatment strategies and how to maximize benefits for patients.

The experts

• Prof. Haifa Kathrin Al-Ali – University Hospital of Halle, Halle (Saale), Germany
• Prof. Jean-Jacques Kiladjian – Université Paris Cité and Saint-Louis Hospital, Paris, France
• Prof. Alessandro Vannucchi – University of Florence, Florence, Italy

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME. 
touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchhaematologyime.org/ 

Listen to key experts from a multidisciplinary team consider the strategies to avoid, mitigate, identify and effectively manage side effects associated with ADCs in patients with metastatic breast cancer.

The multidisciplinary team

• Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France
• Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA
• Clinical oncology pharmacy specialist: Dr Scott Edwards, Dr. H. Bliss Murphy Cancer Center, St. John’s, Newfoundland, Canada

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Gilead Sciences, Inc.

This activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

For further information visit our website: www.touchONCOLOGY.com